Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations

Abstract The U.S. Food and Drug Administration (FDA) emphasizes drug product development by Quality by Design (QbD). Critical material attributes (CMAs) are a QbD element that has an impact on pharmaceutical operations and product quality. Pharmaceutical drugs often crystallize as nee...

Celý popis

Podrobná bibliografie
Hlavní autoři: Azad, Mohammad A, Capellades, Gerard, Wang, Allison B, Klee, David M, Hammersmith, Gregory, Rapp, Kersten, Brancazio, David, Myerson, Allan S
Další autoři: Massachusetts Institute of Technology. Department of Chemical Engineering
Médium: Článek
Jazyk:English
Vydáno: Springer International Publishing 2021
On-line přístup:https://hdl.handle.net/1721.1/132086